Radiotherapy-induced secondary cranial neoplasms in children

Childs Nerv Syst. 2004 Jan;20(1):46-9. doi: 10.1007/s00381-003-0798-x. Epub 2003 Jul 29.

Abstract

Background: Secondary malignant neoplasms (SMN) in CNS tumor survivors has become problem of increasing concern over the last 20 years. These tumors usually occur in a different site from the primary brain tumor several years after treatment.

Case report: We report secondary cranial malignant neoplasms in three patients who were treated with irradiation and chemotherapy for their primary brain tumors. The first case is a male survivor of an orbital rhabdomyosarcoma who developed a meningioma 8 years later. The other two cases are female survivors of ependymomas who were irradiated at the age of 3 and developed secondary gliomas 8 and 17 years after therapy respectively.

Conclusion: Patients carry a risk of developing SMNs many years later since irradiation is still an important part of the treatment. An SMN may have a benign course, as in meningioma, or be a dilemma for the patient, as in glioblastoma.

Publication types

  • Case Reports
  • Comparative Study

MeSH terms

  • Adult
  • Antibodies, Antinuclear / metabolism
  • Antibodies, Monoclonal / metabolism
  • Child
  • Child, Preschool
  • Desmin / metabolism
  • Ependymoma / etiology
  • Female
  • Glial Fibrillary Acidic Protein / metabolism
  • Glioblastoma / etiology
  • Glioblastoma / metabolism
  • Humans
  • Immunohistochemistry / methods
  • Ki-67 Antigen / metabolism
  • Male
  • Meningioma / etiology*
  • Radiotherapy / adverse effects*
  • Radiotherapy / methods
  • Rhabdomyosarcoma, Embryonal / etiology*
  • Rhabdomyosarcoma, Embryonal / metabolism
  • S100 Proteins / metabolism

Substances

  • Antibodies, Antinuclear
  • Antibodies, Monoclonal
  • Desmin
  • Glial Fibrillary Acidic Protein
  • Ki-67 Antigen
  • MIB-1 antibody
  • S100 Proteins